Pfizer-BioNTech's COVID-19 vaccine produces a much weaker immune response against the variant found in South Africa, a new study suggests

Pei-Yong Shi, the study's co-author, said Pfizer's vaccine would likely still be protective in real-life, but that more research was needed.